Better detection of tumor cells in soft tissue sarcoma
Part of Cancer clinical trials.
This trial tests a new blood-test technology to find and study cancer cells in people with advanced soft tissue sarcoma. It aims to improve how we track the disease and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with soft tissue sarcoma (not GIST type)
- Your cancer has spread to other parts of the body or cannot be removed surgically, and your doctor has decided to use a type of chemotherapy called anthracycline
- You have at least one tumor that can be measured on scans (like CT or MRI)
- You are able to perform daily activities with little to no help (ECOG score 0-2)
- You have not had treatment with an anthracycline drug before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a blood test can detect DNA from soft tissue sarcomas. The goal is to see if circulating tumor DNA can help doctors monitor the disease and plan treatment.
This trial tests whether a medicine injected directly into a tumor can shrink or control advanced soft tissue sarcoma. It mainly looks for people whose tumors can be safely injected with a hand exam or ultrasound.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
This trial tests a newer way of giving radiation (spatially fractionated) compared to standard radiation for people with large soft tissue sarcomas. It aims to see if the new method works better.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
This study uses tumor samples from soft tissue sarcoma to create lab models that researchers can test. It may help scientists better understand sarcoma and find more personalized treatment ideas for people like you.
Hear when a new Diagnosis of Soft Tissue Sarcoma (STS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.